Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoantigen”

178 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 178 results

Testing effectiveness (Phase 2)Looking for participantsNCT07002203
What this trial is testing

Personalized Neoantigen Peptide Vaccines for Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRecurrent Cancer+2 more
Seqker Biosciences, Inc. 10
Early research (Phase 1)Study completedNCT04749641
What this trial is testing

Neoantigen Vaccine Therapy Against H3.3-K27M Diffuse Intrinsic Pontine Glioma

Who this might be right for
Diffuse Intrinsic Pontine Glioma
Yang Zhang 16
Early research (Phase 1)UnknownNCT04864379
What this trial is testing

Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Sir Run Run Shaw Hospital 30
Not applicableLooking for participantsNCT06751953
What this trial is testing

Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

Who this might be right for
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University 10
Testing effectiveness (Phase 2)UnknownNCT03171220
What this trial is testing

Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Early research (Phase 1)UnknownNCT04397926
What this trial is testing

Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Sun Yat-sen University 20
Post-approval studies (Phase 4)Study completedNCT02576145
What this trial is testing

Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Daclizumab (Zenapax)

Who this might be right for
Kidney Transplantation
Hoffmann-La Roche 11
Very early researchEnrolling By InvitationNCT07285434
What this trial is testing

Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Squamous Lung Cancer With FGFR1 AmplificationNon-Squamous Non Small Cell Lung Cancer
Biogenea Pharmaceuticals Ltd. 90
Early research (Phase 1)Not Yet RecruitingNCT07695311
What this trial is testing

EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT

Who this might be right for
Ewing SarcomaDesmoplastic Small Round Cell Tumor
Rabi Hanna 24
Early research (Phase 1)Looking for participantsNCT04248569
What this trial is testing

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

Who this might be right for
Fibrolamellar Hepatocellular Carcinoma (FLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 56
Not applicableLooking for participantsNCT06141369
What this trial is testing

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Who this might be right for
Adrenal Cortical CarcinomaMedullary Thyroid CancerThymic Neuroendocrine Carcinoma+1 more
Shanghai Jiao Tong University School of Medicine 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04397003
What this trial is testing

Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Washington University School of Medicine 6
Not applicableAvailableNCT06963697
What this trial is testing

Expanded Access To Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

Who this might be right for
Cancer
Jaime Leandro Foundation for Therapeutic Cancer Vaccines
Early research (Phase 1)Looking for participantsNCT07298200
What this trial is testing

Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Jia Wei 18
Testing effectiveness (Phase 2)Ended earlyNCT04032847
What this trial is testing

ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC

Who this might be right for
Advanced Non Small Cell Lung Cancer
Achilles Therapeutics UK Limited 27
Not applicableLooking for participantsNCT06752057
What this trial is testing

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment

Who this might be right for
Advanced NSCLC
The First Affiliated Hospital of Nanchang University 10
Early research (Phase 1)Ended earlyNCT05641545
What this trial is testing

IVAC-RCC-001: A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in Advanced/Metastatic RCC Patients

Who this might be right for
Advanced Renal Cell Carcinoma
SLK Kliniken Heilbronn GmbH 1
Testing effectiveness (Phase 2)Looking for participantsNCT06675201
What this trial is testing

Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Neoantigen-loaded Dendritic Cell VaccineImmune Checkpoint Inhibitors (ICIs)
Sichuan University 165
Early research (Phase 1)Looking for participantsNCT05013216
What this trial is testing

Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer

Who this might be right for
High Risk CancerPancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 37
Early research (Phase 1)UnknownNCT05317325
What this trial is testing

A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sichuan University 20
Next Page